Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy
Completed
- Conditions
- Chronic Kidney DiseaseSleep Loss
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 353
- Registration Number
- NCT00817674
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Tumor Gene Expression in Women With Ovarian Cancer
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 20
- Registration Number
- NCT00817479
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois
Completed
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 89
- Registration Number
- NCT00817492
- Locations
- 🇺🇸
The University of Illinois at Chicago, Chicago, Illinois, United States
Impact of a Sleep Debt in Middle-Aged and Older Adults
Not Applicable
Completed
- Conditions
- Sleep Restriction
- Interventions
- Other: Sleep restriction
- First Posted Date
- 2009-01-06
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 72
- Registration Number
- NCT00817700
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
Not Applicable
Withdrawn
- Conditions
- Actinic Keratosis
- Interventions
- Drug: 5-FU, Imiquimod or treatment with cryotherapy
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00814528
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Phase 2
Withdrawn
- Conditions
- Hepatitis CHepatitis C Virus
- Interventions
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2013-07-01
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00814606
Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris
Not Applicable
Withdrawn
- Conditions
- Acne Vulgaris
- Interventions
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00814918
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray
Phase 4
Withdrawn
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: placebo, isotonic ciclesonide, hypotonic ciclesonide
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00793858
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 15
- Registration Number
- NCT00791973
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity
Not Applicable
Withdrawn
- Conditions
- MRSA Infection
- Interventions
- Drug: SinofreshDrug: Placebo
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- University of Chicago
- Registration Number
- NCT00790972
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath